The use of growth hormone in the treatment of dwarfism is determined by the degree of symptomatic relief, the patient’s own growth hormone deficiency status, and the treatment usually lasts at least about 3 to 9 months or so. Dwarfism is usually caused by insufficient secretion of growth hormone or insufficient effect of growth hormone, resulting in the patient’s physical growth disorder. The main clinical manifestations are growth retardation, gonadal dysgenesis, and bone retardation. Currently, the main treatment for dwarfism is drug therapy, and commonly used drugs include human growth hormone, insulin-like growth factor-1, etc. During the treatment, patients should be closely monitored. In the process of treatment, we should closely monitor the patient’s physical status and hormone levels, if the patient’s height has reached the expected epiphyseal closure and the body’s hormone levels are normal, you can stop the drug, if it does not meet the above standards, you can continue to use the drug, the general treatment time is at least in the 3 ~ 9 months. For the treatment of dwarfism, whether it is the choice of drugs or the use of drugs, must be in the regular hospital to obtain professional advice before proceeding.